We are live on ! Find out more
CP

Corbenic Partners Portfolio holdings

AUM $380M
1-Year Est. Return 10.47%
This Fund
S&P 500
This Quarter Est. Return
+0.51%
1 Year Est. Return
-10.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$412M
AUM Growth
+$30.8M
Cap. Flow
+$30M
Cap. Flow %
7.28%
Top 10 Hldgs %
67.78%
Holding
312
New
49
Increased
64
Reduced
28
Closed
22

Top Buys

Rank Stock Value
1
DGRO icon
iShares Core Dividend Growth ETF
DGRO
+$5.61M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$4.92M
3
JMST icon
JPMorgan Ultra-Short Municipal Income ETF
JMST
+$3.82M
4
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$2.22M
5
VZ icon
Verizon
VZ
+$1M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$288K
2
MUB icon
iShares National Muni Bond ETF
MUB
+$166K
3
BABA icon
Alibaba
BABA
+$153K
4
GREK
Global X MSCI Greece ETF
GREK
+$85K
5
PG icon
Procter & Gamble
PG
+$27.8K

Sector Composition

Rank Sector Weight
1 Technology 11.17%
2 Consumer Discretionary 7.31%
3 Healthcare 5.06%
4 Communication Services 3.64%
5 Utilities 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GM icon
251
General Motors
GM
$74.7B
$2K ﹤0.01%
+47
New +$2.5K
KULR icon
252
KULR Technology Group
KULR
$117M
$2K ﹤0.01%
125
– –
LLY icon
253
Eli Lilly
LLY
$1.07T
$2K ﹤0.01%
+10
New +$2.47K
M icon
254
Macy's
M
$6.15B
$2K ﹤0.01%
+100
New +$2K
PLL
255
DELISTED
Piedmont Lithium
PLL
$2K ﹤0.01%
+41
New +$2.38K
XYZ
256
Block Inc
XYZ
$45.9B
$2K ﹤0.01%
7
– –
NKLA
257
DELISTED
Nikola Corporation Common Stock
NKLA
$2K ﹤0.01%
7
– –
POTX
258
DELISTED
Global X Cannabis ETF
POTX
$2K ﹤0.01%
30
– –
LDL
259
DELISTED
Lydall, Inc.
LDL
$2K ﹤0.01%
+33
New +$2.03K
ACB
260
Aurora Cannabis
ACB
$165M
$1K ﹤0.01%
8
– –
ALNY icon
261
Alnylam Pharmaceuticals
ALNY
$36.3B
$1K ﹤0.01%
5
– –
APO icon
262
Apollo Global Management
APO
$70.7B
$1K ﹤0.01%
10
– –
FCX icon
263
Freeport-McMoran
FCX
$90B
$1K ﹤0.01%
+25
New +$880
KRUS icon
264
Kura Sushi USA
KRUS
$537M
$1K ﹤0.01%
30
– –
LOW icon
265
Lowe's Companies
LOW
$116B
$1K ﹤0.01%
5
– –
MP icon
266
MP Materials
MP
$7.35B
$1K ﹤0.01%
45
– –
NVAX icon
267
Novavax
NVAX
$1.23B
$1K ﹤0.01%
7
– –
PLAY icon
268
Dave & Buster's
PLAY
$343M
$1K ﹤0.01%
20
– –
PLSE icon
269
Pulse Biosciences
PLSE
$2.09B
$1K ﹤0.01%
65
– –
URBN icon
270
Urban Outfitters
URBN
$5.99B
$1K ﹤0.01%
+50
New +$1.79K
WM icon
271
Waste Management
WM
$95.9B
$1K ﹤0.01%
10
– –
TRHC
272
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$1K ﹤0.01%
50
– –
ATO icon
273
Atmos Energy
ATO
$29.9B
– –
-75
Closed -$7K
BEN icon
274
Franklin Resources
BEN
$16.9B
– –
-165
Closed -$5K
BFH icon
275
Bread Financial
BFH
$4.21B
– –
-103
Closed -$9K
9 10
11
12 13

Similar funds

MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return
TF
TRH Financial North Liberty, Iowa $297M AUM 7.9% 1-Year Est. Return
RIM
Reynolds Investment Management Greenville, South Carolina $281M AUM
PPW
Pinnacle Private Wealth Andover, Massachusetts $256M AUM
HA
HYA Advisors Springfield, Missouri $255M AUM 7.11% 1-Year Est. Return

Corbenic Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Corbenic Partners held 312 positions worth $412M, up 8.1% from $382M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Corbenic Partners deployed $30M of net new capital in Q3 2021, opening 49 new positions and adding to 64 existing holdings. Its largest new stake was Moderna: 64 shares worth $25K.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $288K trimmed.

  • Corbenic Partners's largest Q3 2021 buy was Moderna: 64 shares worth $25K.
  • Corbenic Partners added most to iShares Core Dividend Growth ETF in Q3 2021, an estimated $5.61M increase.
  • Corbenic Partners's biggest Q3 2021 reduction was Pfizer, cutting an estimated $288K.
  • Corbenic Partners fully exited Global X MSCI Greece ETF in Q3 2021, selling an estimated $85K.
  • Corbenic Partners's ten largest holdings make up 68% of its $412M portfolio in Q3 2021.
  • Corbenic Partners opened 49 new positions and closed 22 in Q3 2021.
  • Corbenic Partners's portfolio value rose 8.1% quarter-over-quarter to $412M.

Based on Corbenic Partners's 13F filing for Q3 2021, filed 13 Oct 2021.